BIOS Capital Management, LP Q1 2025 Filing

Filed May 14, 2025

Portfolio Value

$79.2B

Holdings

6

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (6 positions)

#StockSharesValue% PortfolioType
1
ACTUACTUATE THERAPEUTICS INC
9,893,651$67.0B84.59%
2
LTRNLANTERN PHARMA INC
1,207,709$4.3B5.40%
3
RNTXREIN THERAPEUTICS INC
1,690,751$3.0B3.78%
4
CGTXCOGNITION THERAPEUTICS INC
6,000,000$2.5B3.19%
5
INABEURIN8BIO INC
8,600,001$1.4B1.80%
6
IRDOPUS GENETICS INC
995,249$977.1M1.23%